Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Jared Kelly

CEO at Oncolytics Biotech Inc (ONCY)

Purchase track record

Not enough history. Based on 1 purchase with a full 90 days of price history.

—
Avg. 90-day return-17.9%
vs. S&P 500-28.0%
Beat the market0%
Paper profit on buys−$12K
Total bought / sold$34K / $0

Reported trades

Filed Stock Type Shares Price Value Since
Mar 13SEC ONCYOncolytics Biotech Inc Buy 5,050114,050 held (+5%) $0.96 $5K -41.7%
Feb 13SEC ONCYOncolytics Biotech Inc Buy 5,60079,500 held (+8%) $0.84 $5K -33.3%
Feb 13SEC ONCYOncolytics Biotech Inc Buy 29,500109,000 held (+37%) $0.84 $25K -33.3%
  • Buy

    CEO Jared Kelly bought $5K of ONCY at $0.84 — first open-market purchase in our records.

  • Buy

    CEO Jared Kelly bought $25K of ONCY at $0.84 — largest purchase by this insider in our records; raises the stake by 37%.